Trial Profile
A randomised, single centre, crossover study to evaluate the effect of Pramlintide on Postprandial Glucose Fluxes in Type 1 Diabetes patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Mar 2016
Price :
$35
*
At a glance
- Drugs Pramlintide (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 08 Mar 2016 New trial record
- 01 Mar 2016 Results published in the Journal of Clinical Endocrinology and Metabolism